发明名称 |
TARGETED MODIFIED IL-1 FAMILY MEMBERS |
摘要 |
The present disclosure relates to a modified Interleukin-1 (IL-1) family member cytokine, with reduced activity via its cytokine receptor, wherein said interleukin-1 family member cytokine is specifically delivered to target cells. Preferably, the IL-1 family member cytokine is a mutant, more preferably it is a mutant IL-1 with low affinity to the IL-1 receptor, wherein said mutant IL-1 is specifically delivered to target cells. The targeting is preferably realized by fusion of the modified IL-1 family member cytokine to a targeting moiety, preferably an antibody or antibody-like molecule. The disclosure relates further to the use of such targeted modified IL-1 family member cytokine to treat diseases. |
申请公布号 |
EP3022226(A1) |
申请公布日期 |
2016.05.25 |
申请号 |
EP20140735574 |
申请日期 |
2014.07.04 |
申请人 |
VIB VZW;UNIVERSITEIT GENT;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;UNIVERSITÉ MONTPELLIER 2;CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE MONTPELLIER |
发明人 |
TAVERNIER, JAN;GERLO, SARAH;PEELMAN, FRANK;UZÉ, GILLES |
分类号 |
C07K16/28;C07K14/545;C07K16/32 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|